>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS

October 13 - 17 2012, 12:00 AM - 12:00 AM

ANESTHESIOLOGY 2012

>

FDA MEDWATCH ALERTS

RSS

May 16, 2012

Hydromorphone Hydrochloride Recall

Summary:

Hydromorphone Hydrochloride Recall

April 18, 2012

Morphine Sulfate Injection USP, 4 mg/mL (C-II), 1 mL fill in 2.5 mL Carpuject by Hospira, Inc: Recall - May Contain More Than Intended Fill Volume

Summary:

Customer report of two Carpujects syringes containing more than the 1 mL labeled fill volume. Opioid pain medications such as morphine have life-threatening consequences if overdosed. Those consequences can include respiratory depression (slowed breathing or suspension of breathing), and low blood pressure.

March 05, 2012

Cardiac Science Powerheart, CardioVive, CardioLife; GE Responder and Responder Pro; and Nihon-Kohden Automated External Defibrillators (AEDs): Class I Recall - Defective Component

Summary: FDA notified healthcare professionals and medical care organizations of the Class 1 recall of the listed AEDs which contain a component that may fail unexpectedly due to a defect. If the component were to fail during a rescue attempt, the AED may not deliver defibrillation therapy, causing serious adverse health consequences, including death. The unit’s self test may not detect the failure or impending failure of the component.

>

ASA FEATURED PRODUCT

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-12CE

... Read more »

Single Copies, Member Price: $300

Template 4

The World Health Organization (WHO) analgesic ladder consists of a hierarchy of oral pharmacologic interventions designed to effectively treat pain of increasing magnitude. The ladder presents a framework for the rational use of oral medication before application of other techniques of drug administration. Opioid therapy is considered the mainstay approach for patients with moderate or severe pain. The type of medication administered is sequentially escalated from nonopioids (e.g., nonsteroidal antiinflammatory drugs (NSAIDs) adjuvants to opioids used for mild to moderate pain (codeine, dihydrocodeine, oxycodone (compounded with a coanalgesic), hydrocodone, dihydrocodone) adjuvants to opioids commonly used for severe pain (morphine, hydromorphone, methadone, oxycodone (without compounding), fentanyl or levorphanol). Adjuvant medications are listed in template 7. (Modified with permission from WHO: Cancer pain relief and palliative care: Report of a WHO expert committee. Geneva, World Health Organization, 1990 (technical report series, no. 804).)